Company / Cash per Share
Twist Bioscience Corp Cash per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.06
FY2025
5-year range
$3.06 / $9.65
FY2021-FY2025
Trend
-21.5%
vs FY2024
Sector context
#73 of 207
Health Care
What the data says
At $3.06, Twist Bioscience Corp's cash per share ranks #73 of 207 in the Health Care sector. Cash per Share has declined for 4 consecutive years, from $9.65 in FY2021 to $3.06 in FY2025.
Based on SEC 10-K filings.
3.06 in FY2025 with a 5-year CAGR of +5.1%.
Declined from $5.04 to $3.06 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -24.2%
- 5-Year CAGR
- +5.1%
- 10-Year CAGR
- -
Sector benchmark
#73 of 207 in Health CareTop 35% of 207This company $3.06 Sector average $67.39
▼
-95.5% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's cash per share has declined for 4 consecutive years.
- In FY2025, cash per share decreased 21.5% year-over-year.
- Ranks #73 out of 207 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.06 | -21.5% |
| FY2024 | $3.90 | -22.5% |
| FY2023 | $5.04 | -28.3% |
| FY2022 | $7.03 | -27.2% |
| FY2021 | $9.65 | +303.9% |
| FY2020 | $2.39 | +40.4% |
| FY2019 | $1.70 | -100.0% |
| FY2018 | $28914.07 | +224283071.0% |
| FY2017 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026